about
Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the FutureAquaporin-4 and Cerebrovascular DiseasesDouble Roles of Macrophages in Human Neuroimmune Diseases and Their Animal ModelsThe Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future PerspectivesInternational consensus diagnostic criteria for neuromyelitis optica spectrum disordersPhysiological roles of aquaporin-4 in brainDeletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficitsOptical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderImmunology of neuromyelitis optica during pregnancyTreatment of neuromyelitis optica: state-of-the-art and emerging therapiesHeadache in Neuromyelitis Optica.Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Magnetic resonance imaging in neuromyelitis optica.Transient hyperckemia in the setting of neuromyelitis optica (NMO).[Contribution of spinal cord biopsy to the differential diagnosis of longitudinal extensive transverse myelitis].Devic's syndrome in aquaporin-4 antibody negative patient. What we need to know …Systemic Lupus Erythematosus (SLE) Complicated by Neuromyelitis Optica (NMO - Devic's Disease): Clinic-Pathological Report and Review of the Literature.Mechanisms of Autoantibody-Induced Pathology.The potential roles of aquaporin 4 in malignant gliomasAquaporins: important but elusive drug targets.Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?Potential therapeutic benefit of C1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat modelNeuromyelitis optica IgG causes placental inflammation and fetal death.Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO.Retinal glycoprotein enrichment by concanavalin a enabled identification of novel membrane autoantigen synaptotagmin-1 in equine recurrent uveitisNeuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.Discovery of peptoid ligands for anti-aquaporin 4 antibodiesComparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patientsBrain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis opticaInhibitor(s) of the classical complement pathway in mouse serum limit the utility of mice as experimental models of neuromyelitis optica.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Association between neuromyelitis optica and tuberculosis in a Chinese population.Markedly increased IP-10 production by blood-brain barrier in neuromyelitis opticaAquaporins as diagnostic and therapeutic targets in cancer: how far we are?A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α
P2860
Q26740107-3AFEAAFA-7CAB-4BCF-8E89-CDAA11D0B3DFQ26741216-F9DF5FC4-D345-438F-9FB4-095A362148AFQ26749131-EB1E20C9-AD83-4B50-948A-5E59A5D33AB1Q26767391-D333E41A-3328-4501-AF0C-C300180C5204Q26824579-04A369AA-ACCB-4B13-B3EF-78CCC64B8309Q26866009-672CD54D-1D2B-43C1-9732-90CF8CE02135Q27301321-32663E1E-0269-451D-AE26-DAB0EDA8EE8FQ28076588-9773ECA3-144E-4DBE-A67B-55818663037DQ28078470-CAA69A0C-2A21-4D42-9907-DE8324EFCA30Q28245749-329C0AB1-10EA-4850-B161-F7BD34B815F1Q30235347-3C973752-2A9E-48ED-A815-6D0D67AEAA32Q30649660-92837983-F64D-4BB9-A048-DC23E59AE684Q30785267-845C4388-EE70-48CB-B887-6B5ABA16C9E4Q30820823-E894BB4F-FED1-47A0-A51C-D5E6CAE1D5DCQ30826839-6A3E5806-BD46-4D95-8AAF-C5D45A519D1AQ30844319-012A2A35-5182-48F9-ACE0-49857226C769Q31130607-DA0E76F5-99A0-49A7-9500-D844B41ADF63Q33734731-98B23EE0-E0B4-47F0-9F5F-093EDBC756D9Q33740580-8630E99E-8054-474C-8AA4-71F246BAA990Q33762106-DCD9FBDB-D9B3-4ABE-A93C-60C2980BE5F6Q33792739-061BD072-7510-4378-B574-6F84D6064E78Q33911142-F0B242EA-6EDF-497C-A9A8-0D462CF48A9EQ34142474-1F49BECA-8209-40F4-968F-254C4D2DB596Q34168084-570F0ABA-1862-4306-9F04-5264FE737E70Q34173376-AFAF82FC-2AAC-4439-988C-AFB757FD5171Q34368609-D4816B63-2602-45FF-96CD-E7C0025E3AFFQ34377212-AD62CA15-8144-45D8-AB7C-D635D3A3E55BQ34510602-FD4B40E3-3B97-42C4-AA9D-9560FC38845BQ34529121-AFDEE4B6-345C-46E6-8240-41C668F8270BQ34545836-E0A2348A-7534-42AD-B779-4EE8FBB76E02Q34632417-70F5580E-051C-4CCA-A958-A9773E603284Q34687502-E7B313C4-1492-4F3E-AA1B-1EF23601E01CQ34793304-BD4D806B-39A2-4C82-B7FE-FFFCBCCC4487Q34919661-47248E96-7CB6-43E6-8843-452215E9A151Q35013113-51F61D91-54D1-4923-9356-2E9762790918Q35052199-6C460942-542D-4BD4-B561-51D22FEADC0BQ35098917-85694990-7BF5-4FCE-9CFB-4985D88C33FCQ35219651-CE71CF50-20C4-4F3E-AF28-D135F9A45EBAQ35245970-EFB6A85C-0AC8-4B63-A25B-4994A6BD49EEQ35290680-A1476276-6F2E-4B6F-B4CD-C8F916F544E6
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Aquaporin 4 and neuromyelitis optica
@ast
Aquaporin 4 and neuromyelitis optica
@en
Aquaporin 4 and neuromyelitis optica
@nl
type
label
Aquaporin 4 and neuromyelitis optica
@ast
Aquaporin 4 and neuromyelitis optica
@en
Aquaporin 4 and neuromyelitis optica
@nl
prefLabel
Aquaporin 4 and neuromyelitis optica
@ast
Aquaporin 4 and neuromyelitis optica
@en
Aquaporin 4 and neuromyelitis optica
@nl
P2860
P3181
P1433
P1476
Aquaporin 4 and neuromyelitis optica
@en
P2093
A S Verkman
P2860
P304
P3181
P356
10.1016/S1474-4422(12)70133-3
P407
P577
2012-05-16T00:00:00Z